[1] CALIÒ A N, BRUNELLI M, GOBBO S, et al. Cathepsin K: a novel diagnostic and predictive biomarker for renal tumors[J]. Cancers,2021,13(10):2441. doi:  10.3390/cancers13102441
[2] DAI R C, WU Z T, CHU H Y, et al. Cathepsin K: the action in and beyond bone[J]. Front Cell Dev Biol,2020,8:433. doi:  10.3389/fcell.2020.00433
[3] LI Z Q, HOU W S, ESCALANTE-TORRES C R, et al. Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate[J]. J Biol Chem,2002,277(32):28669-28676. doi:  10.1074/jbc.M204004200
[4] 国家药典委员会. 中华人民共和国药典一部: 2020年版[M]. 北京: 中国医药科技出版社, 2020.
[5] 梁文娜, 李西海, 胡柳, 等. 二至丸抑制绝经后骨质疏松大鼠骨代谢紊乱的作用机制研究[J]. 中医正骨, 2017, 29(11):1-7,14. doi:  10.3969/j.issn.1001-6015.2017.11.001
[6] 胡科. 二至丸对骨质疏松性股骨颈骨折术后愈合及髋关节功能的影响[J]. 现代中西医结合杂志, 2017, 26(4):384-386. doi:  10.3969/j.issn.1008-8849.2017.04.014
[7] 俞益火, 陈久毅, 王建. 二至丸治疗绝经后骨质疏松症的疗效观察[J]. 中国中医骨伤科杂志, 2011(4):42-43.
[8] 蔡秀江, 黄美艳, 丁安伟, 等. 二至丸考源及药理作用研究进展[J]. 中国实验方剂学杂志, 2011, 17(23):272-275. doi:  10.3969/j.issn.1005-9903.2011.23.080
[9] 蒋益萍, 吴岩斌, 秦路平, 等. 墨旱莲组分中组织蛋白酶K非活性位点抑制剂研究[J]. 药学学报, 2017, 52(6):936-942. doi:  10.16438/j.0513-4870.2016-1234
[10] 钟询龙, 王若伦, 段炼, 等. 基于UPLC/Q-TOF-MS技术分析女贞子与墨旱莲配伍协同增效的物质基础[J]. 中国医院药学杂志, 2017, 37(19):1887-1891. doi:  10.13286/j.cnki.chinhosppharmacyj.2017.19.02
[11] 李雯, 庞旭, 韩立峰, 等. 中药墨旱莲化学成分研究[J]. 中国中药杂志, 2018, 43(17):3498-3505. doi:  10.19540/j.cnki.cjcmm.20180625.001
[12] 刘美红, 邹峥嵘. 女贞子化学成分, 药理作用及药动学研究进展[J]. 热带亚热带植物学报, 2022(003):030.446-460.
[13]

SHARMA V, PANWAR P, O'DONOGHUE A J, et al. Structural requirements for the collagenase and elastase activity of cathepsin K and its selective inhibition by an exosite inhibitor[J]. Biochem J,2015,465(1):163-173. doi:  10.1042/BJ20140809
[14]

XU D, LYU Y, CHEN X W, et al. Fructus Ligustri Lucidi ethanol extract inhibits osteoclastogenesis in RAW264.7 cells via the RANKL signaling pathway[J]. Mol Med Rep,2016,14(5):4767-4774. doi:  10.3892/mmr.2016.5849
[15]

LIU Y Q, HONG Z L, ZHAN L B, et al. Wedelolactone enhances osteoblastogenesis by regulating Wnt/β-catenin signaling pathway but suppresses osteoclastogenesis by NF-κB/c-fos/NFATc1 pathway[J]. Sci Rep,2016,6:32260. doi:  10.1038/srep32260
[16]

TEPEL C, BRÖMME D, HERZOG V, et al. Cathepsin K in thyroid epithelial cells: sequence, localization and possible function in extracellular proteolysis of thyroglobulin[J]. J Cell Sci, 2000, 113 Pt 24: 4487-4498.
[17]

VASSALLE C, IERVASI G. Cathepsin K: a classical bone biomarker in cardiovascular disease: the heart is not alone anymore[J]. Atherosclerosis,2013,228(1):36-37. doi:  10.1016/j.atherosclerosis.2013.01.042